Equities

Venture Life Group PLC

VLG:LSE

Venture Life Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)40.63
  • Today's Change-0.875 / -2.11%
  • Shares traded161.22k
  • 1 Year change-3.27%
  • Beta0.2720
Data delayed at least 20 minutes, as of Apr 29 2024 11:38 BST.
More ▼

Profile data is unavailable for this security.

About the company

Venture Life Group PLC is a United Kingdom-based consumer self-care company. The principal activities of the Company are the development, manufacturing, and commercialization of healthcare products, including medical devices, food supplements and cosmetics for the ageing population. The Company's product portfolio includes products, such as the UltraDEX and Dentyl oral care product ranges; the Balance Activ range in the area of women's intimate healthcare; the Lift Glucose and Glucogel product ranges for hypoglycaemia; Gelclair, Xonrid, and Pomi-T for oncology support products provide symptomatic relief for some of the side effects associated with cancer and its treatment; the Procto-eze Plus product ranges for hemorrhoids, and other Dermatology products. The Company operates through two segments: Venture Life Brands and Customer Brands. The Company's subsidiaries include Venture Life Limited, Lubatti Limited, Periproducts Limited, HL Healthcare Ltd, and Venture Life Healthcare Ltd.

  • Revenue in GBP (TTM)51.41m
  • Net income in GBP921.00k
  • Incorporated2005
  • Employees165.00
  • Location
    Venture Life Group PLCUnit 12, The Courtyard, Eastern RoadBRACKNELL RG12 2XBUnited KingdomGBR
  • Phone+44 13 4457 8004Fax+44 13 4474 2970
  • Websitehttps://www.venture-life.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Sareum Holdings Plc0.00-4.26m28.05m5.0028.05m5.00
Science in Sport PLC65.93m-7.07m28.71m158.0028.71m158.00
CRUSHMETRIC Group Ltd398.65k-880.15k30.10m20.0030.10m20.00
Redx Pharma PLC4.20m-33.16m35.01m101.0035.01m101.00
Arecor Therapeutics PLC3.38m-9.42m41.81m51.0041.81m51.00
Venture Life Group PLC51.41m921.00k52.50m165.0052.50m165.00
e-Therapeutics plc475.00k-8.27m57.26m38.0057.26m38.00
Poolbeg Pharma PLC0.00-4.89m59.00m12.0059.00m12.00
Celadon Pharmaceuticals PLC20.74k-8.06m65.81m--65.81m--
Eco Animal Health Group Plc88.46m-1.62m72.83m228.0072.83m228.00
Data as of Apr 29 2024. Currency figures normalised to Venture Life Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

67.59%Per cent of shares held by top holders
HolderShares% Held
Slater Investments Ltd.as of 11 Jan 202422.77m18.00%
BGF Investment Management Ltd.as of 16 Feb 202411.40m9.01%
Hargreaves Lansdown Asset Management Ltd.as of 31 Dec 202310.60m8.38%
River Global Investors LLPas of 31 Dec 20239.85m7.79%
Close Asset Management Ltd.as of 31 Dec 20239.35m7.39%
Stonehage Fleming Investment Management Ltd.as of 31 Dec 20238.49m6.71%
Chelverton Asset Management Ltd.as of 31 Dec 20237.03m5.56%
Octopus Investments Ltd.as of 20 May 20223.29m2.60%
Quilter Cheviot Ltd.as of 02 Nov 20231.42m1.12%
J. M. Finn & Co. Ltd.as of 02 Nov 20231.31m1.03%
More ▼
Data from 29 Sep 2023 - 12 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.